-
-
Call more information
660-596-2224 -
The FDA has approved a buprenorphine implant as a maintenance treatment for opioid dependence. Probuphine, made up of four inch-long rods placed subdermally on the inside of the upper arm, is designed to deliver a steady dose of buprenorphine over a 6-month period. The implant is approved for patients who are already on low-to-moderate doses […]
Read MoreOpioids commonly are used for pain management in patients with osteoarthritis. However, a new study has found that reducing opioid use by half prior to surgery may lead to better functional outcomes. By Thomas G. Ciccone and Forest Tennant, MD, DrPH Interview with Kevin J. Bozic, MD, MBA Managing pain from knee or hip osteoarthritis (OA) is oftentimes […]
Read MoreNumerous peer-reviewed studies have attempted to validate a correlation between patient pain and meteorological conditions, but documenting any sort of repeatable linkage remains a scientific enigma. By Mark A. Young, MD, MBA, FACP and Brandon Bukovitz, BS Patients suffering from chronic pain frequently attribute their symptoms to changes in the weather. In fact, a study revealed that a […]
Read MoreAuthors: Beatrice Beck-Schimmer, M.D. et al Anesthesiology published on 5 2016. Abstract Background: One-lung ventilation during thoracic surgery is associated with hypoxia–reoxygenation injury in the deflated and subsequently reventilated lung. Numerous studies have reported volatile anesthesia–induced attenuation of inflammatory responses in such scenarios. If the effect also extends to clinical outcome is yet undetermined. We hypothesized that […]
Read MoreA bupivacaine injection along the tract of the nephrostomy site at the time of percutaneous nephrolithotomy (PCNL) reduces postoperative pain as well as the need for narcotic medication, according to study results presented at the 2016 Annual Meeting of the American Urological Association (AUA). Lead author James Mason, MD, University of Florida, Gainesville, Florida, speaking […]
Read More